San Diego, CA
Booth: 429
With ready-to-use assays, custom models and high-throughput screening capabilities, Ncardia offers the precision and reproducibility needed to move neuroscience forward.
Stop by our booth at the Society for Neuroscience 2025 Annual Meeting for an inside look at our iPSC-based platforms — including dopaminergic neurons, motor neurons, microglia and neural mixes — and how they’re built for scalability, reproducibility and translational insight across neurodegenerative, neuroinflammatory and psychiatric disease areas.
Whether you’re advancing early-stage discovery, modeling disease mechanisms or improving CNS safety assessments, it’s time to accelerate your next breakthrough.
Check out our Presentation!
A Human iPSC-Based Platform for Functional and Molecular Evaluation of ALS Therapeutics
Targeting TDP-43 Pathology
Speaker: Shushant Jain, Ph.D., Director Discovery Technology
Presentation Time: Tuesday, November 18, 2025, 2:45 PM - 3:00 PM
Location/Room: SDCC Rm 11
Session Type: Nanosymposium
Session Number: NANO039
Session Title: ALS: Human Genetics, Cellular Mechanisms, and Potential Treatments
Check out our Posters!
A human iPSC based platform for functional toxicity of CNS targeted RNA therapeuticsSession Number: PSTR441.17
Session Date and Time: Wednesday, November 19, 1:00 PM - 5:00 PM
Evaluation of human induced pluripotent stem cell (hiPSC) derived tri-culture as in vitro model for Alzheimer's Disease
Session Number: PSTR110.25
Session Date and Time: Sunday, November 16, 1:00 PM - 5:00 PM
Development of iPSC based Parkinson's disease model for drug discovery
Session Number: PSTR438.05
Presentation Time: Wednesday, November 19, 1:00 PM - 5:00 PM
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.